Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Pfaar

Showing results (21-30 of 122) with videos related to

Pageof 13
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 23, 2012
Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose-ranging safety studyL Klimek, P Schendzielorz, R Pinol, et al.
HNO|July 9, 2009
[Cluster immunotherapy of persistent allergic rhinoconjunctivitis. Safety aspects of induction therapy with mite depot allergen preparations]O Pfaar, R Mösges, K Hörmann, et al.
Immunology and Allergy Clinics of North America|May 3, 2011
Allergen-specific immunotherapy: which outcome measures are useful in monitoring clinical trials?O Pfaar, J Kleine-Tebbe, K Hörmann, et al.
HNO|April 26, 2012
[Mechanism of action of nasal glucocorticosteroids in the treatment of allergic rhinitis. Part 2: Practical aspects of application]L von Bernus, P Högger, O Pfaar, et al.
Allergy|July 22, 2010
Immunotherapy with depigmented-polymerized mixed tree pollen extract: a clinical trial and responder analysisO Pfaar, D S Robinson, A Sager, et al.
HNO|May 10, 2012
[Urticaria. Basic knowledge for the ENT specialist]V Daut, P Staubach, K Hörmann, et al.
Rhinology|April 4, 2012
Cyclamen europaeum nasal spray, a novel phytotherapeutic product for the management of acute rhinosinusitis: a randomized double-blind, placebo-controlled trialO Pfaar, J Mullol, C Anders, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 22, 2006
Levocetirizine in patients with chronic idiopathic urticaria: results of a multicenter clinical practice studyO Pfaar, H Wrede, C Barth, et al.
Allergy|August 19, 2014
A high polymerized grass pollen extract is efficacious and safe in a randomized double-blind, placebo-controlled study using a novel up-dosing cluster-protocolL Klimek, J Uhlig, R Mösges, et al.
European Annals of Allergy and Clinical Immunology|October 11, 2011
Sustained clinical efficacy of sublingual immunotherapy with a high-dose grass pollen extractP Kuna, B Samolinski, M Worm, et al.
Pageof 13

Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 23, 2012
Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose-ranging safety studyL Klimek, P Schendzielorz, R Pinol, et al.
HNO|July 9, 2009
[Cluster immunotherapy of persistent allergic rhinoconjunctivitis. Safety aspects of induction therapy with mite depot allergen preparations]O Pfaar, R Mösges, K Hörmann, et al.
Immunology and Allergy Clinics of North America|May 3, 2011
Allergen-specific immunotherapy: which outcome measures are useful in monitoring clinical trials?O Pfaar, J Kleine-Tebbe, K Hörmann, et al.
HNO|April 26, 2012
[Mechanism of action of nasal glucocorticosteroids in the treatment of allergic rhinitis. Part 2: Practical aspects of application]L von Bernus, P Högger, O Pfaar, et al.
Allergy|July 22, 2010
Immunotherapy with depigmented-polymerized mixed tree pollen extract: a clinical trial and responder analysisO Pfaar, D S Robinson, A Sager, et al.
HNO|May 10, 2012
[Urticaria. Basic knowledge for the ENT specialist]V Daut, P Staubach, K Hörmann, et al.
Rhinology|April 4, 2012
Cyclamen europaeum nasal spray, a novel phytotherapeutic product for the management of acute rhinosinusitis: a randomized double-blind, placebo-controlled trialO Pfaar, J Mullol, C Anders, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 22, 2006
Levocetirizine in patients with chronic idiopathic urticaria: results of a multicenter clinical practice studyO Pfaar, H Wrede, C Barth, et al.
Allergy|August 19, 2014
A high polymerized grass pollen extract is efficacious and safe in a randomized double-blind, placebo-controlled study using a novel up-dosing cluster-protocolL Klimek, J Uhlig, R Mösges, et al.
European Annals of Allergy and Clinical Immunology|October 11, 2011
Sustained clinical efficacy of sublingual immunotherapy with a high-dose grass pollen extractP Kuna, B Samolinski, M Worm, et al.
Pageof 13